Literature DB >> 19906903

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Surender Khurana1, Philip J Norris, Michael P Busch, Barton F Haynes, Susan Park, Pretty Sasono, Koleka Mlisana, Abdool Karim Salim, Frederick M Hecht, Joseph Mulenga, Elwyn Chomba, Eric Hunter, Susan Allen, George Nemo, Isaac R Rodriguez-Chavez, Joseph B Margolick, Hana Golding.   

Abstract

HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19906903      PMCID： PMC2812287          DOI： 10.1128/JCM.01573-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes.

Authors:  Surender Khurana; James Needham; Susan Park; Bonnie Mathieson; Michael P Busch; George Nemo; Phillipe Nyambi; Susan Zolla-Pazner; Suman Laal; Joseph Mulenga; Elwyn Chomba; Eric Hunter; Susan Allen; James McIntyre; Indira Hewlett; Sherwin Lee; Shixing Tang; Elliot Cowan; Chris Beyrer; Marcus Altfeld; Xu G Yu; Anatole Tounkara; Ousmane Koita; Anatoli Kamali; Nga Nguyen; Barney S Graham; Deborah Todd; Peter Mugenyi; Omu Anzala; Eduard Sanders; Nzeera Ketter; Patricia Fast; Hana Golding
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

2.  Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus.

Authors:  Tracey E Wilson; Yolanda Barrón; Mardge Cohen; Jean Richardson; Ruth Greenblatt; Henry S Sacks; Mary Young
Journal:  Clin Infect Dis       Date:  2002-01-09       Impact factor: 9.079

3.  Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.

Authors:  E S Gray; P L Moore; I A Choge; J M Decker; F Bibollet-Ruche; H Li; N Leseka; F Treurnicht; K Mlisana; G M Shaw; S S Abdool Karim; C Williamson; L Morris
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

5.  Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.

Authors:  Georgia D Tomaras; Nicole L Yates; Pinghuang Liu; Li Qin; Genevieve G Fouda; Leslie L Chavez; Allan C Decamp; Robert J Parks; Vicki C Ashley; Judith T Lucas; Myron Cohen; Joseph Eron; Charles B Hicks; Hua-Xin Liao; Steven G Self; Gary Landucci; Donald N Forthal; Kent J Weinhold; Brandon F Keele; Beatrice H Hahn; Michael L Greenberg; Lynn Morris; Salim S Abdool Karim; William A Blattner; David C Montefiori; George M Shaw; Alan S Perelson; Barton F Haynes
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Gender difference in HIV RNA levels: a meta-analysis of published studies.

Authors:  Sonia Napravnik; Charles Poole; James C Thomas; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

7.  Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies.

Authors:  Surender Khurana; James Needham; Bonnie Mathieson; Isaac R Rodriguez-Chavez; Andrew T Catanzaro; Robert T Bailer; Jerome Kim; Vicky Polonis; David A Cooper; Jan Guerin; Michael L Peterson; Marc Gurwith; Nga Nguyen; Barney S Graham; Hana Golding
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

9.  Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.

Authors:  Richard E Haaland; Paulina A Hawkins; Jesus Salazar-Gonzalez; Amber Johnson; Amanda Tichacek; Etienne Karita; Olivier Manigart; Joseph Mulenga; Brandon F Keele; George M Shaw; Beatrice H Hahn; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

10.  Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.

Authors:  Giota Touloumi; Nikos Pantazis; Abdel G Babiker; Sarah A Walker; Olga Katsarou; Anastasia Karafoulidou; Angelos Hatzakis; Kholoud Porter
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177
View more
  3 in total

1.  H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.

Authors:  Surender Khurana; Pretty Sasono; Annette Fox; Van Kinh Nguyen; Quynh Mai Le; Quang Thai Pham; Tran Hien Nguyen; Thanh Liem Nguyen; Peter Horby; Hana Golding
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 2.  HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians.

Authors:  Yegor Voronin; Helene Zinszner; Carissa Karg; Katie Brooks; Robert Coombs; John Hural; Renee Holt; Pat Fast; Mary Allen
Journal:  Vaccine       Date:  2015-01-31       Impact factor: 3.641

3.  The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update.

Authors:  Merina Elahi; Noha Eshera; Nkosazana Bambata; Helen Barr; Beverly Lyn-Cook; Julie Beitz; Maria Rios; Deborah R Taylor; Marilyn Lightfoote; Nada Hanafi; Lowri DeJager; Paddy Wiesenfeld; Pamela E Scott; Emmanuel O Fadiran; Marsha B Henderson
Journal:  J Womens Health (Larchmt)       Date:  2016-02-12       Impact factor: 2.681
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.